NPI: 1174500458 · HARTSVILLE, SC 29550 · Certified Registered Nurse Anesthetist · NPI assigned 12/28/2005
Authorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
| Authorized Official | TRAYLOR, JOHNETTA (DIRECTOR) |
| NPI Enumeration Date | 12/28/2005 |
Other providers sharing the same authorized official: TRAYLOR, JOHNETTA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 98,138 | $1.88M |
| 2019 | 96,316 | $1.95M |
| 2020 | 81,489 | $2.09M |
| 2021 | 93,548 | $2.78M |
| 2022 | 108,570 | $3.48M |
| 2023 | 105,461 | $3.75M |
| 2024 | 99,022 | $2.48M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 31,792 | 24,819 | $1.92M |
| 81025 | 10,713 | 9,924 | $1.91M | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4,356 | 3,857 | $1.46M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9,177 | 8,681 | $1.44M |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,618 | 6,996 | $1.27M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 40,530 | 36,082 | $1.12M |
| 80053 | Comprehensive metabolic panel | 31,547 | 25,949 | $1.10M |
| 87070 | 10,771 | 10,034 | $581K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 13,673 | 11,371 | $491K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,480 | 3,185 | $407K |
| 80048 | Basic metabolic panel (calcium, ionized) | 11,932 | 9,796 | $380K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 13,813 | 12,853 | $327K |
| 85610 | 6,200 | 5,320 | $301K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 13,193 | 11,724 | $242K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,854 | 4,319 | $210K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,803 | 2,560 | $203K |
| 59025 | Fetal non-stress test | 1,448 | 789 | $200K |
| 87280 | 3,459 | 3,289 | $190K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 24,761 | 21,881 | $188K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,919 | 1,725 | $186K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 5,805 | 1,576 | $185K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,529 | 2,533 | $160K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,380 | 2,170 | $142K |
| J7050 | Infusion, normal saline solution, 250 cc | 2,695 | 1,613 | $139K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,614 | 2,401 | $132K |
| 73610 | 1,564 | 1,439 | $126K | |
| 73562 | 1,916 | 1,704 | $124K | |
| 81002 | 6,664 | 6,072 | $113K | |
| 71046 | Radiologic examination, chest; 2 views | 4,768 | 4,362 | $111K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 329 | 312 | $108K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,114 | 2,469 | $106K |
| 81001 | 16,469 | 14,594 | $104K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 6,909 | 2,012 | $104K |
| 73130 | 1,220 | 1,121 | $91K | |
| 86900 | 2,425 | 2,178 | $91K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 13,052 | 3,114 | $90K |
| 73630 | 1,955 | 1,774 | $89K | |
| 82962 | 7,766 | 4,228 | $88K | |
| 71045 | Radiologic examination, chest; single view | 11,559 | 9,731 | $86K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 994 | 935 | $84K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 553 | 514 | $81K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 401 | 362 | $79K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8,695 | 8,113 | $73K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7,388 | 5,701 | $72K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,084 | 1,899 | $69K |
| 97161 | 1,029 | 974 | $68K | |
| 73030 | 1,167 | 1,052 | $64K | |
| 97162 | 807 | 742 | $64K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,466 | 1,440 | $62K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 185 | 165 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 48,253 | 38,310 | $59K |
| 80306 | 3,952 | 3,617 | $56K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 4,200 | 2,358 | $52K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 12,814 | 10,840 | $51K |
| 84702 | 3,105 | 2,368 | $49K | |
| 72100 | 869 | 823 | $49K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 665 | 571 | $47K |
| 74018 | 1,428 | 1,299 | $45K | |
| 88304 | 1,022 | 970 | $44K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11,554 | 10,011 | $44K |
| 76819 | Fetal biophysical profile; without non-stress testing | 470 | 289 | $41K |
| 93971 | 259 | 243 | $41K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 14,350 | 11,583 | $40K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 8,930 | 8,441 | $36K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,240 | 3,026 | $36K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,625 | 2,495 | $30K |
| 73110 | 467 | 442 | $29K | |
| 82803 | 1,134 | 899 | $28K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,128 | 1,025 | $27K |
| 84484 | 8,278 | 6,493 | $24K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 152 | 151 | $24K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,410 | 1,367 | $23K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,049 | 603 | $21K |
| 82565 | 1,300 | 1,115 | $21K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 856 | 789 | $14K |
| 42830 | 61 | 60 | $14K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 2,110 | 667 | $14K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,611 | 1,942 | $13K |
| 82272 | 690 | 623 | $13K | |
| 73502 | 331 | 307 | $13K | |
| 97597 | 347 | 245 | $12K | |
| 83605 | 3,253 | 2,714 | $12K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 185 | 165 | $12K |
| 93017 | 488 | 442 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,087 | 927 | $11K |
| 85378 | 1,705 | 1,514 | $11K | |
| 10060 | 100 | 92 | $11K | |
| 87210 | 1,179 | 1,125 | $10K | |
| 12001 | 93 | 89 | $9K | |
| 96376 | 3,199 | 2,098 | $9K | |
| 71250 | 68 | 44 | $9K | |
| 76536 | 80 | 75 | $9K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 7,409 | 5,839 | $8K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 15 | 14 | $8K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 176 | 172 | $8K |
| 72040 | 88 | 81 | $8K | |
| 95782 | 12 | 12 | $7K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 416 | 371 | $7K |
| G0378 | Hospital observation service, per hour | 3,179 | 2,752 | $6K |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,133 | 1,599 | $6K |
| 74022 | 242 | 218 | $5K | |
| 94664 | 1,389 | 1,207 | $5K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,818 | 1,506 | $5K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 810 | 775 | $5K |
| 95811 | 12 | 12 | $5K | |
| 97032 | 71 | 31 | $4K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 43 | 40 | $4K |
| 87186 | 4,904 | 4,312 | $4K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 418 | 378 | $4K |
| 87077 | 2,224 | 2,030 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,712 | 2,606 | $4K |
| 36600 | 1,166 | 903 | $4K | |
| 83690 | 5,951 | 5,293 | $4K | |
| 90715 | 200 | 191 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,139 | 2,621 | $3K |
| 76642 | 82 | 78 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 2,094 | 1,942 | $3K |
| 76830 | Ultrasound, transvaginal | 14 | 14 | $3K |
| 84145 | 453 | 385 | $3K | |
| 86850 | 1,678 | 1,494 | $3K | |
| 84112 | 24 | 24 | $3K | |
| 80320 | 1,801 | 1,685 | $3K | |
| 30140 | 125 | 124 | $3K | |
| 59050 | 328 | 200 | $3K | |
| J3490 | Unclassified drugs | 3,518 | 3,041 | $3K |
| 87088 | 4,016 | 3,620 | $3K | |
| 94060 | 65 | 52 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 146 | 115 | $3K |
| 72131 | 32 | 32 | $2K | |
| 73080 | 63 | 60 | $2K | |
| 73590 | 71 | 61 | $2K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 889 | 850 | $2K |
| 82150 | 993 | 912 | $2K | |
| 84520 | 1,116 | 947 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 394 | 363 | $2K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1,371 | 1,303 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 18 | 13 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 46 | 43 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,435 | 2,285 | $2K |
| 84439 | 3,708 | 3,535 | $2K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 508 | 316 | $2K |
| 83735 | 9,128 | 6,993 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | 8,288 | 7,706 | $2K |
| 76770 | 30 | 26 | $1K | |
| 99001 | 1,395 | 1,334 | $1K | |
| 29580 | 68 | 24 | $1K | |
| 80076 | 312 | 287 | $1K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 221 | 200 | $1K |
| 97116 | 118 | 67 | $1K | |
| 83880 | 3,272 | 2,601 | $1K | |
| 73552 | 24 | 14 | $1K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 786 | 691 | $984.01 |
| 86141 | 1,174 | 1,051 | $960.72 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 41 | 38 | $958.76 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 7,556 | 6,604 | $958.03 |
| 76801 | 25 | 25 | $868.38 | |
| 73140 | 17 | 12 | $863.27 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,342 | 4,008 | $654.23 |
| 80177 | 29 | 27 | $624.56 | |
| 85651 | 1,646 | 1,505 | $598.64 | |
| 51702 | 15 | 12 | $582.58 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 702 | 577 | $489.34 |
| 86592 | 264 | 258 | $474.59 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,081 | 1,831 | $470.69 |
| 10061 | 17 | 12 | $405.74 | |
| 87045 | 16 | 15 | $400.40 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 14 | 12 | $384.60 |
| 82607 | 2,514 | 2,382 | $384.28 | |
| 70486 | 16 | 16 | $367.42 | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 82 | 71 | $305.46 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,639 | 2,505 | $287.74 |
| 80061 | Lipid panel | 4,216 | 4,015 | $287.59 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,298 | 4,703 | $277.74 |
| 87040 | 3,111 | 2,666 | $274.64 | |
| 85014 | 212 | 172 | $257.61 | |
| 85730 | 4,710 | 4,066 | $252.00 | |
| 82728 | 741 | 637 | $223.19 | |
| 97166 | 14 | 12 | $218.29 | |
| 82550 | 162 | 138 | $202.72 | |
| 83540 | 1,026 | 944 | $149.65 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 325 | 290 | $135.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 5,362 | 4,876 | $116.83 |
| 82950 | 1,441 | 1,380 | $97.37 | |
| 87205 | 1,325 | 1,150 | $74.49 | |
| 82570 | 230 | 213 | $69.68 | |
| 87075 | 83 | 76 | $65.14 | |
| 84156 | 163 | 145 | $62.86 | |
| 84153 | 433 | 403 | $59.95 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 815 | 794 | $48.68 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,768 | 2,578 | $29.54 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 829 | 661 | $27.90 |
| 86901 | 2,424 | 2,177 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 3,516 | 3,314 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 68 | 59 | $0.00 |
| G0379 | Direct admission of patient for hospital observation care | 77 | 60 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 404 | 366 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 770 | 728 | $0.00 |
| 82746 | 336 | 320 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 382 | 345 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 53 | 37 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 147 | 83 | $0.00 |
| C1769 | Guide wire | 13 | 12 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 281 | 234 | $0.00 |
| 85018 | 199 | 160 | $0.00 | |
| 94762 | 485 | 419 | $0.00 | |
| 83550 | 70 | 67 | $0.00 | |
| 88307 | 12 | 12 | $0.00 | |
| 87046 | 16 | 15 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 14 | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 19 | 19 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 50 | 45 | $0.00 |
| 84134 | 30 | 26 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 13 | 13 | $0.00 |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 17 | 15 | $0.00 |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 33 | 31 | $0.00 |
| 84100 | 330 | 242 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,090 | 900 | $0.00 |
| 94799 | 206 | 144 | $0.00 | |
| 84550 | 80 | 65 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 95 | 74 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 231 | 193 | $0.00 |
| 76000 | 37 | 36 | $0.00 | |
| 94726 | 50 | 40 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 299 | 272 | $0.00 |
| 82247 | 44 | 25 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 35 | 29 | $0.00 |
| 94150 | 17 | 15 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 94 | 74 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 14 | 12 | $0.00 |
| 94729 | 47 | 38 | $0.00 | |
| 85044 | 30 | 24 | $0.00 | |
| 82248 | 35 | 33 | $0.00 | |
| 83525 | 25 | 25 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 12 | 12 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 12 | 12 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 36 | 32 | $0.00 |
| 84466 | 22 | 18 | $0.00 | |
| 83020 | 12 | 12 | $0.00 | |
| 86038 | 13 | 12 | $0.00 |